High numbers of regulatory T cells and especially high Treg:CD8 + T cell ratios in the tumor microenvironment are associated with a poor prognosis in many malignancies [5], and it has been shown that Treg depletion results in reduced cancer progression or tumor rejection by the induction of CTL mediated immunity [6, 7]. The gene discussed is CD8A; the disease is neoplasm.